UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08901-2008, USA.
J Subst Abuse Treat. 2010 Jun;38(4):384-93. doi: 10.1016/j.jsat.2010.03.006. Epub 2010 Apr 2.
Compared to the general population, smokers with schizophrenia (SCZ) have reduced success in quitting smoking with usual approaches. This study tested two manualized behavioral counseling approaches-Treatment of Addiction to Nicotine in Schizophrenia (TANS) or Medication Management (MM)-for smokers who were motivated to quit. Individual counseling sessions were provided by mental health clinicians in mental health settings, along with nicotine patch. The two treatments varied in intensity and frequency of sessions. Eighty-seven subjects were randomized and attended at least one treatment session. Twenty-one percent (n = 18) of participants had continuous abstinence at 12 weeks after the target quit date, which was not significantly different between conditions (15.6% TANS vs. 26.2% MM, chi(2) = 1.50, p = .221). Smokers in both groups significantly reduced smoking as measured by cigarettes per day and expired carbon monoxide. Findings support that mental health clinicians can be trained to effectively help smokers with SCZ maintain tobacco abstinence.
与普通人群相比,患有精神分裂症 (SCZ) 的吸烟者在通过常规方法戒烟方面成功率较低。本研究测试了两种针对有戒烟意愿的吸烟者的手册化行为咨询方法——治疗精神分裂症中的尼古丁成瘾 (TANS) 或药物管理 (MM)。心理健康临床医生在心理健康环境中提供个体咨询会议,并提供尼古丁贴片。两种治疗方法在治疗次数和频率上有所不同。87 名受试者被随机分配,并至少参加了一次治疗会议。在目标戒烟日期后 12 周,有 21%(n=18)的参与者持续戒烟,这两种治疗方法之间没有显著差异(TANS 组为 15.6%,MM 组为 26.2%,chi(2) = 1.50,p =.221)。两组吸烟者的吸烟量(每天吸烟量和呼出的一氧化碳量)均显著减少。研究结果支持可以培训心理健康临床医生来有效帮助患有 SCZ 的吸烟者保持戒烟状态。